Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Using a market index as a benchmark offers transparency, comparability, and alignment with market performance, aiding consistent evaluations.
28,506 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Bitcoin stabilizes after a sharp pullback, but traders warn that reclaiming a key level is essential to avoiding rene...
Roomvu unveils Engage Pages, an AI-powered landing page builder designed for mortgage and real estate pros. The tool ...
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
JB Straubel’s initial pitch to Elon Musk missed the mark on aviation, but his pivot to electric cars launched Tesla t...
Intel leads a high-stakes comeback race among legacy hardware players, while HP and Xerox wrestle with structural hea...
Ethereum stays near the pivotal $1,500 support as a potential double bottom forms. A breakout above $1,800 could spar...
NVIDIA faces bearish chatter, yet supporters argue three durable drivers could lift the stock. AI demand, cash return...
As mid-2026 trading picks up, McDonald’s demonstrates stronger growth and cash flow versus Pfizer, which relies on in...
Trump unveils a plan to monetize passage through the Strait of Hormuz, triggering market moves and raising questions ...
AI-driven capex is lifting lithography demand, placing ASML at the center of a multiyear upgrade cycle. This piece ex...
Bitcoin hovers in the low-to-mid $60,000s after failing to clear a major resistance zone. With momentum subdued, trad...